RegisterLogin

Decernotinib

CAT: 0804-HY-12469-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-12469-01Size:5 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Decernotinib is a potent, orally active JAK3 inhibitor, with Kis of 2.5, 11, 13 and 11 nM for JAK3, JAK1, JAK2, and TYK2, respectively.
CAS Number
[944842-54-0]
Product Name Alternative
VX-509; VRT-831509
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Decernotinib.html
Purity
99.91
Solubility
DMSO : ≥ 50 mg/mL
Smiles
C[C@](C(NCC(F)(F)F)=O)(CC)NC1=NC(C2=CNC3=NC=CC=C32)=NC=C1
Molecular Formula
C18H19F3N6O
Molecular Weight
392.38
Precautions
H302, H315, H319, H335
References & Citations
[1]Mahajan S, et al. VX-509 is a potent and selective Janus kinase 3 (JAK3) inhibitor that attenuates inflammation in animal models of autoimmune disease. J Pharmacol Exp Ther. 2015 Mar 11. pii: jpet.114.221176.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
JAK1; JAK2; JAK3; Tyk2

Related Products

CatalogName

Alternative Products

CatalogName
445918-01Decernotinib
M16768-01Decernotinib
MBS386385-01Decernotinib
MBS3606762-01Decernotinib
T2636-01Decernotinib
TRC-D225580-100MGDecernotinib
BUP07327-01Decernotinib
A14012-2Decernotinib 2mg
A14012-500Decernotinib 500mg
TRC-D225582-50MGDecernotinib-D3

Popular Products